Department of Health
Five million people at high risk of Type 2 diabetes
PHE data the most up to date, accurate and robust available.
Five million people in England have blood sugar levels indicating a high risk of developing Type 2 diabetes, according to a new report published yesterday by Public Health England (PHE).
The report, compiled by PHE’s National Cardiovascular Health Intelligence Network (NCVIN), provides the most accurate and robust estimate of how many people over 16 in England have blood sugar levels in a range indicating a high risk of developing Type 2 diabetes, otherwise known as non-diabetic hyperglycaemia.
It was commissioned by the NHS Diabetes Prevention Programme (NHS DPP), which will support people in reducing their risk of developing Type 2 diabetes by helping them lose weight, be more active and have a healthier diet.
The new estimate further underlines the need to act on Type 2 diabetes, especially as it already results in 22,000 early deaths and costs the NHS £8.8billion every year.
An evidence review also published yesterday by PHE shows programmes similar to the NHS DPP can be successful in preventing 26% of people at high risk of Type 2 diabetes from going on to develop the condition. People supported by diabetes prevention programmes lose on average 1.57kg more weight than those not on a programme aiming to significantly reduce diabetes risk.
Both reports have shaped what the NHS DPP will offer at least 9 months of information, support, group and one-to-one sessions on weight loss, physical activity and diet. Practitioners, clinicians, academics and the public are currently being consulted on a proposed outline of the programme.
Consultation responses will further inform the programme, with a phased national rollout starting in 2016.
Duncan Selbie, Chief Executive of PHE, said:
We know how to lower the risk of developing Type 2 diabetes: lose weight, exercise and eat healthily, but it’s hard to do it alone. PHE’s evidence review shows that supporting people along the way will help them protect their health and that’s what our prevention programme will do.
Professor Jonathan Valabhji, National Clinical Director for Diabetes and Obesity, NHS England said:
There are too many people on the cusp of developing Type 2 diabetes and we can change that. The growing body of evidence makes us confident that our NHS Diabetes Prevention Programme will reduce the numbers of those at risk going on to develop the debilitating disease.
Barbara Young, Chief Executive of Diabetes UK, said:
Having high blood glucose levels significantly increases your risk of developing Type 2 diabetes, which is a serious health condition which affects 2.9 million people in England, and can lead to devastating complications such as blindness, amputations and stroke, and ultimately early death.
This is why it is really important that people at high risk of developing Type 2 diabetes are given evidence-based support to reduce their risk. As well as helping to reduce the human cost of Type 2 diabetes, this would also go a long way to helping to reduce costs to the NHS.
The NHS spends 10% of its entire budget managing diabetes and unless we get better at preventing Type 2 diabetes this figure will rise to unsustainable levels.
The data on non-diabetic hyperglycaemia is broken down by local authority (LA) for the first time, ranging from 8.5% of people in Brighton and Hove to 14% in Harrow. Higher rates are found in areas with large ethnic minority populations or older populations, or both: the groups traditionally at higher risk of Type 2 diabetes.
Lifestyle factors, including weight, physical activity levels and diet, are important like the inherent factors of ageing and ethnic background in determining the risk of developing Type 2 diabetes. The NHS DPP will focus on providing support to participants on changing their behaviour in these areas to reduce their risk.
According to the evidence review, programmes more aligned with the NICEguidance on preventing or delaying the onset of Type 2 diabetes help people lose on average 3kg more weight and significantly reduce blood sugar levels.
Aside from reducing incidences of Type 2 diabetes, the NHS DPP also aims to reduce the life-changing complications associated with the disease, like heart, stroke, kidney, eye and foot problems, and reduce costs to the NHS in the long term.
People identified with a high risk of developing Type 2 diabetes, either through an NHS Health Check or through an existing blood test result will be offered a place on the NHS DPP when it launches in 2016.
Public Health England press office
Telephone020 7654 8400
Out of hours telephone020 8200 4400
The report on non-diabetic hyperglycaemia was produced by the National Cardiovascular Health Intelligence Network (NCVIN), a group of cardiovascular experts co-ordinated by PHE
Using 5 years’ of the latest available Health Survey for England data, the new analysis gives the programme the most accurate and up to date picture of how many people have non-diabetic hyperglycaemia.
The report includes local authority breakdown.
The PHE review collated studies conducted since the highly regarded studies of the late 1990s and early 2000s in the US, Finland, China, India and Japan, including as yet unpublished, pragmatic, “real world” diabetes prevention solutions. It updated the 2012 review underpinning the NICEguidelines on preventing Type 2 diabetes in high risk groups.
The PHE evidence review is available from the GOV.UK website.
The NHS Diabetes Prevention Programme is a joint commitment from NHS England, Public Health England and Diabetes UK, to deliver evidence-based behaviour change interventions at scale to people at high risk of developing Type 2 diabetes to support them in reducing their risk
The NHS DPP has used the PHE evidence review and NCVIN data to develop a core components framework, currently out for consultation
NICE published guidelines on identifying people at high risk of developing Type 2 diabetes and the provision of effective interventions for them.
Latest News from
Department of Health
UK health ministers’ statement on JCVI advice (13 April 2021)13/04/2021 14:15:00
A joint statement from the 4 UK health ministers on JCVI advice for phase 2 of the COVID-19 vaccination programme.
Visas extended for thousands of frontline health and care workers09/04/2021 15:22:00
Thousands of crucial frontline health workers and their dependents will be granted free visa extensions, Home Secretary Priti Patel has announced today.
Findings from the latest COVID-19 REACT-1 study published09/04/2021 10:10:10
Findings from the 10th report of REACT-1, one of the country’s largest studies into COVID-19 infections in England, have been published by Imperial College London and Ipsos MORI.
Statement on AstraZeneca Covid-19 vaccine following MHRA update08/04/2021 11:20:00
The Government's statement following updated advice from the UK's medicines regulator.
Twice weekly rapid testing to be available to everyone in England07/04/2021 10:10:10
Everyone in England will be able to access free, regular, rapid coronavirus (COVID-19) testing from 9 April, the Government has announced.
Two visitors allowed in care homes to reunite with loved ones06/04/2021 15:10:00
Care home residents to be allowed a second regular visitor indoors, with tests required before entry and PPE provided.
5 million people in the UK receive second dose of COVID-19 vaccine06/04/2021 13:10:00
More than 5 million people in the UK have received their second dose of a coronavirus (COVID-19) vaccine.
Work begins for UK Health Security Agency to protect the nation01/04/2021 15:15:00
The new UK Health Security Agency (UKHSA) has today been formally established with Dr Jenny Harries starting her first day as the Chief Executive of the new agency.